Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Helena Giannakaki-Zimmermann
Outcomes When Switching From a Pro Re Nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration
Ophthalmologica
Medicine
Ophthalmology
Sensory Systems
Related publications
Treat-And-Extend Versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Switching Frompro Re Natato Treat-And-Extend Regimen Improves Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Comment on ‘Transitioning to Intravitreal Aflibercept Following a Previous Treat-And-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: 24-Month Results’
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Five-Year Outcomes of a Personalized Pro Re Nata Treatment Regimen With Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Intravitreal Injection of Ranibizumab Using A pro Re Nata Regimen for Age-Related Macular Degeneration and Vision-Related Quality of Life
Clinical Ophthalmology
Ophthalmology
One-Year Outcomes of 1 Dose Versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial
Journal of Ophthalmology
Ophthalmology
Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-And-Extend Regimen
Ophthalmic Surgery Lasers and Imaging Retina
Medicine
Ophthalmology
Surgery
Treat-And-Extend Therapy Using Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: 2-Year Real-World Practice Data From Slovenia
BMC Ophthalmology
Medicine
Ophthalmology
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
